Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum ABBOTT LABORATORIES ABT

Healthcare Medical Devices

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the... see more

Add To Watchlist

Bullboard (NYSE:ABT)

View:

Post by QuantumEquity04on Nov 25, 2024 9:34am

Abbott's Steady Climb: Time to Jump In?

ABT is showing resilience at $117.76 with a strong diversified portfolio in diagnostics and medical devices. There's still room to move upward, especially with steady revenue growth. Thinking of ...more

12

Post by whytestockson Jul 24, 2024 4:32pm

Game On: Real Madrid Summer Tour Returns to U.S.

News; $ABT Game On: Real Madrid Summer Tour Returns to U.S.Real Madrid will visit the U.S. and support the fight against malnutrition during the Soccer Champions Tour 2024. NORTHAMPTON, MA ...more

51

QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp

posted Nov 25, 2024 9:00am by Q Precious & Battery Metals Corp.

The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more

Post by whytestockson Feb 04, 2024 8:45am

2 Healthcare Dividend Kings to Buy and Hold Forever

Breaking News: $ABT 2 Healthcare Dividend Kings to Buy and Hold Forever2024-02-04 08:20:00 ET Dividend Kings are unquestionably among the top picks for income-seeking investors. These are companies ...more

113

Post by whytestockson Jan 24, 2024 7:30pm

Abbott Laboratories Surpasses Q4 Sales Expectations, Despite

Just In: $ABT Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand | BenzingaAbbott Laboratories@(NYSE:ABT) posted higher sales of $10.24 billion in the fourth ...more

125

Post by ivosmithon Nov 27, 2023 12:45am

Blood Gas and Electrolyte Analyzer Market Outlook 2023-2028

According to the latest research report, the global blood gas and electrolyte analyzer market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.9 ...more

133

Post by PressReleaseon Nov 29, 2022 7:05am

New Press Release - NOTICE For Investors In ABT: Lawsuit against Abbott Laboratories announced by Shareholders Foundation

San Diego, California--(Newsfile Corp. - November 29, 2022) - The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Abbott Laboratories (NYSE: ABT).Investors who purchased Abbott Laboratories (NYSE: ABT) shares prior to February 2021 and continue...read article.

Post by PressReleaseon Nov 17, 2022 9:01am

New Press Release - Abbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology

The Consumer Technology Association (CTA) awards Abbott multiple CES 2023 Innovation Awards for industry-leading health technologiesAbbott's Aveir™ single-chamber (VR) leadless pacemaker, Proclaim™ Plus SCS system, Alinity® m Monkeypox PCR test honoredOther recent Abbott innovation honors include...read article.

Post by PressReleaseon Oct 31, 2022 3:11pm

New Press Release - ABT FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT

NEW YORK, Oct. 31, 2022 /PRNewswire/ --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021 and June 8, 2022, both dates inclusive (the "Class Period"), of the important October 31, 2022 lead...read article.

Post by PressReleaseon Oct 31, 2022 12:41pm

New Press Release - ABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline

New York, New York--(Newsfile Corp. - October 31, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District...read article.

Post by PressReleaseon Oct 31, 2022 11:02am

New Press Release - Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Abbott Laboratories (ABT) Investors of Class Action and to Actively Participate

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Abbott Laboratories (“Abbott” or “the Company”) (NYSE: ABT) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired...read article.

Post by PressReleaseon Oct 31, 2022 5:45am

New Press Release - CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Abbott Investors of a Lead Plaintiff Deadline of October 31, 2022

NEW YORK, Oct. 31, 2022 /PRNewswire/ -- Attention Abbott Laboratories ("Abbott") (NYSE: ABT) shareholders:The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors. This lawsuit is on behalf of all persons or entities who purchased or otherwise...read article.

Post by PressReleaseon Oct 30, 2022 10:37am

New Press Release - Abbott Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 31, 2022 to Discuss Your Rights - ABT

New York, New York--(Newsfile Corp. - October 30, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District...read article.

Post by PressReleaseon Oct 30, 2022 8:24am

New Press Release - Abbott Laboratories Deadline Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 30, 2022) - Faruqi & Faruqi, LLP, a leading national securities law...read article.

Post by PressReleaseon Oct 28, 2022 10:50pm

New Press Release - ABBOTT LABORATORIES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 31, 2022 to file lead plaintiff applications in a securities class action lawsuit against Abbott Laboratories (NYSE: ABT), if they...read article.

Post by PressReleaseon Oct 28, 2022 5:56pm

New Press Release - Abbott Laboratories Deadline Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 28, 2022) - Faruqi & Faruqi, LLP, a leading national securities law...read article.

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities

Featured News Links

One Property, One Focus on Advancing this Gold Project in Ontario

Options Trading for Retiring: Key Strategies in Balancing Retirement Income